Both in Pharmaceuticals
Kiniksa Pharmaceuticals International vs Corcept Therapeutics
Over the past year KNSA returned +149.4% and CORT returned +11.4%; their daily moves had a correlation of 0.11.
KNSA +149.4% CORT +11.4%Growth of $1, one year, split-adjusted
| Metric | KNSA | CORT |
|---|---|---|
| Price | $96.12 | $79.22 |
| Market cap | $7.55B | $8.56B |
| Today | +3.03% | −3.31% |
| 1 month | +24.7% | −33.7% |
| 6 months | +65.1% | +51.9% |
| Year to date | +133.0% | +127.6% |
| 1 year | +156.5% | +6.8% |
| Revenue growth (YoY) | +58.1% | +31.7% |
| Gross margin | 90.3% | 98.4% |
| Net margin | 16.6% | 16.8% |
| P/E (TTM) | 68.9× | 157.2× |
| Price / sales | 8.0× | 10.3× |
| Net cash | $462.9M | $308.2M |
| Dividend yield | — | — |
| Volatility (60d) | 54.2% | 59.5% |
| Short % of float | 9.6% | 9.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).